Compare Sanofi India with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ABBOTT INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ABBOTT INDIA SANOFI INDIA/
ABBOTT INDIA
 
P/E (TTM) x 39.3 53.1 74.1% View Chart
P/BV x 8.0 17.2 46.7% View Chart
Dividend Yield % 1.1 0.4 271.6%  

Financials

 SANOFI INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ABBOTT INDIA
Mar-19
SANOFI INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6,8408,834 77.4%   
Low Rs4,6305,458 84.8%   
Sales per share (Unadj.) Rs1,203.11,731.1 69.5%  
Earnings per share (Unadj.) Rs165.3211.9 78.0%  
Cash flow per share (Unadj.) Rs209.9219.9 95.4%  
Dividends per share (Unadj.) Rs84.0065.00 129.2%  
Dividend yield (eoy) %1.50.9 161.0%  
Book value per share (Unadj.) Rs963.6945.2 101.9%  
Shares outstanding (eoy) m23.0321.25 108.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.84.1 115.5%   
Avg P/E ratio x34.733.7 102.9%  
P/CF ratio (eoy) x27.332.5 84.1%  
Price / Book Value ratio x6.07.6 78.7%  
Dividend payout %50.830.7 165.7%   
Avg Mkt Cap Rs m132,078151,848 87.0%   
No. of employees `0003.33.5 94.7%   
Total wages/salary Rs m4,0684,356 93.4%   
Avg. sales/employee Rs Th8,393.810,555.5 79.5%   
Avg. wages/employee Rs Th1,232.41,249.9 98.6%   
Avg. net profit/employee Rs Th1,153.01,292.2 89.2%   
INCOME DATA
Net Sales Rs m27,70836,786 75.3%  
Other income Rs m8971,133 79.2%   
Total revenues Rs m28,60537,919 75.4%   
Gross profit Rs m6,2356,047 103.1%  
Depreciation Rs m1,027169 607.0%   
Interest Rs m723 31.1%   
Profit before tax Rs m6,0986,989 87.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2922,485 92.2%   
Profit after tax Rs m3,8064,503 84.5%  
Gross profit margin %22.516.4 136.9%  
Effective tax rate %37.635.6 105.7%   
Net profit margin %13.712.2 112.2%  
BALANCE SHEET DATA
Current assets Rs m15,92227,610 57.7%   
Current liabilities Rs m6,2358,569 72.8%   
Net working cap to sales %35.051.8 67.5%  
Current ratio x2.63.2 79.3%  
Inventory Days Days6460 105.7%  
Debtors Days Days2127 76.2%  
Net fixed assets Rs m7,5391,057 713.3%   
Share capital Rs m230213 108.2%   
"Free" reserves Rs m21,96219,873 110.5%   
Net worth Rs m22,19220,086 110.5%   
Long term debt Rs m00-   
Total assets Rs m29,83929,409 101.5%  
Interest coverage x872.1311.6 279.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 74.2%   
Return on assets %12.815.4 83.0%  
Return on equity %17.222.4 76.5%  
Return on capital %27.534.9 78.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,587369 2,056.3%   
Fx outflow Rs m7,1454,918 145.3%   
Net fx Rs m442-4,549 -9.7%   
CASH FLOW
From Operations Rs m3,7394,991 74.9%  
From Investments Rs m-731-2,570 28.4%  
From Financial Activity Rs m-1,972-1,428 138.1%  
Net Cashflow Rs m1,036993 104.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 7.9 182.3%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.1 61.4%  
Shareholders   15,184 18,270 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT PHARMOVA   BIOCON   

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 17, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS